Donna LaVoie, President and CEO of LaVoieHealthScience, Announced as Spokeies Award Winner in two Categories

The SPOKEies® are the first awards program to honor the best in-house spokespeople representing brands, non-profits and corporations. The mission behind the SPOKEies® is to acknowledge and reward leaders who communicate honestly and effectively on behalf of their organizations. The winners were judged based on their ability to achieve organizational goals, creativity, trust and authenticity as a spokesperson.

The winners share their advice with the communications community on May 3, 2018 on a live multi-channel video stream called “Spokesperson Secrets to Build Your Brand.” A full list of honorees can be found on this Awards Page which also includes quotes and tips from the winners.

Donna has been recognized as the winner of the “Corporate Emerging Growth/Startups” and “C-Suite Leader Corporate” categories.

LaVoieHealthScience Presents How to Engage Busy Biotech Reporters

This not-to-be-missed Q&A panel, moderated by Donna LaVoie, Founder and CEO of LaVoieHealthScience, will feature top reporters and editors discussing paid, earned and online coverage of today’s health and science scene, including:

  • Gideon Gil, Managing Editor, STAT
  • Lisa Henderson, Group Editorial Director, Applied Clinical Trials and Pharmaceutical Executive
  • Lisa LaMotta, Senior Editor, BioPharma Dive
  • Angus Macaulay, Chief Revenue Officer, STAT
  • Max Stendahl, Biotech Reporter, Boston Business Journal

What You’ll Hear:

  • What top reporters are covering
  • The Good, The Bad & The Ugly of pitches they receive every day
  • Anatomy of a winning pitch
  • How to establish a relationship based on mutual value
  • Creative ways to engage beyond traditional coverage
  • Pros & cons of paid versus earned, shared media

Travel Coordinates:

  • Parking garage located at 800 Technology Square, Cambridge, MA 02139
  • T Stop: Kendall Square, Red Line is approximately 2 blocks away

Where?

The Collaboration Room at MassBio, 300 Technology Square, 8th Floor, Cambridge, MA 02139

When?

Friday, April 27, 2018. | 9:00 – 10:30 AM

RSVP

There is limited space, RSVP HERE today!

The Power of Mentorship: My Story on The Business of Health and Science

The Power of Mentorship: My Story on The Business of Health and Science

 

Wednesday, February 28th was an important day in the history of the biotechnology industry. It was #RareDiseaseDay and Henri Termeer’s birthday. It was also a day to remember the #biotech pioneers who helped to transform #KendallSquare into a global #lifescience hub in #Cambridge.

It was with great respect that I attended the dedication ceremony Wednesday in Henri’s honor to rename the Kendall Square North Plaza “Henri A. Termeer Square.” I am proud to be part of this community and team of amazing people.

My memories of the early days at @SanofiGenzyme (formerly Genzyme) when I worked with Henri and the founding management team are vast and deep. Henri had many talents but one key one was his ability to bring people together for the benefit of a cause – in this case for patients. He and the management team at @Genzyme pushed things forward with tremendous force to create an industry of #innovation, especially New England region. He said yes when others said no. And, he kept searching for answers to questions to create major advances in how patients are treated with rare diseases.

Henri was the person who encouraged me to become a storyteller in our industry — to be counted for what I believed in and to push for answers to questions. He also told me that I would have my own firm one day. And, here we are @LaVoieHealthScience in our 17th year in business serving health and science companies around the globe with specialized thinking in strategic communications. 

It’s life’s mentors that impact who you are and what you become, and I am thankful for the inspiration he and others gave me as we continue with passion for this amazing field. Wishing you the same.

Xontogeny’s Biotech Entrepreneur Webinar Series

Title:  Xconomy Insight & Xontogeny present: Starting a Biotech Company: Where to Begin

Day/Date/Time: Wednesday, March 7, 1:00 – 2:00 pm EST

Description: Launching a biotech company is a daunting task. It takes conviction, passion, and an idea or technology that offers a clear path from science to a valuable asset that will attract investors. So how do you know if you have a great idea? Once you have formulated a narrative around the concept, where and how do you begin to create a company? What are the key steps to take – and the potential mistakes that you need to avoid? What are the tradeoffs in creating a virtual company with a lean staff versus a broader team to support the organizational needs?

This webinar will draw on years of experience from legal, seed investors, and tech transfer experts to explore these questions. These panelists will discuss the best kind of structure for the company, where (and how) to begin looking for financial support, and how you can build a solid foundation for your biotech company. The webinar is designed to provide the basic knowledge and guidance that will give your nascent company the best chances for success.

Link to Registration:  https://event.on24.com/wcc/r/1589149/FF4262C8797CFF8267F5EFD1B8141CF4?partnerref=Xontogeny1

LaVoieHealthScience to Begin Working with Life Sciences Corridor

LaVoieHealthScience to Begin Working with Life Sciences Corridor

 

Competitive Contract Recognized LHS’ Health and Science Connectedness

 

Boston, MA – January 16, 2018 —  LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced engagement with the Life Sciences Corridor, a partnership among five Greater Boston cities including Boston, Braintree, Cambridge, Quincy and Somerville. LHS will leverage content and optimize social media channels on behalf of Life Sciences Corridor to ensure visibility for the Corridor’s unique offering of talent, facilities and connections for life science companies.

The Life Sciences Corridor is an initiative launched by the mayors of the five Greater Boston communities to promote the robust life sciences sector along the MBTA red line. Nicknamed “the brain train,” the cluster represents more than 460 companies within the life science industry sector. With the goal of attracting business from outside the region as well as retaining businesses within the region, the Corridor also promotes cross collaboration among universities, institutions and businesses.

“As contributors to the health and life science ecosystem in the Greater Boston Area, LHS welcomes the opportunity to work with an initiative whose mission includes helping companies understand the advantages and offerings of companies in the Corridor,” said Donna L. LaVoie, President and CEO of LaVoieHealthScience. “We have been aligned with leaders in the life science sector since its infancy more than 15 years ago and we look forward to connecting with the various companies and helping grow this already flourishing industry.”

“For years, Cambridge has been planning for new major economic development opportunities, including the Volpe Center and Cambridge Crossing projects, and we are looking forward to continuing our collaboration with Boston, Quincy, Somerville, and Braintree to support the life sciences industry in Massachusetts,” said Cambridge City Manager Louis A. DePasquale. “The partnership between the five cities of the Life Sciences Corridor is helping transform the regional economy by bolstering support for hundreds of life sciences companies.”

“Boston is home to a growing network of businesses, entrepreneurs, researchers, employees, and job seekers actively contributing to life saving technologies and innovation within the region’s life sciences cluster,” said John Barros, Chief of Economic Development in the City of Boston. “By collaborating with our neighboring cities, all connected by the Red Line of our transit system, we are leveraging shared resources to further position the Boston region as a global leader for the life sciences industry.”

“For anyone outside of Massachusetts seeking to grow their business, the Boston region has always been defined broadly, and this partnership will embrace that,” said Braintree Mayor Sullivan.

“It’s an opportunity that benefits everyone involved,” said Quincy Mayor Koch. “This partnership will capture the immediate impacts on business development and institutional growth.”

“It’s great to see these five cities working with a local agency that specializes in the life science field,” said Somerville Mayor Curtatone. “They understand not only the local ecosystem, but also how to target outside, national audiences to drive growth.”

About LaVoieHealthScience

LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 29 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients, and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. LaVoieHealthScience represents other life science leaders such as Ampio Pharmaceuticals, Biotechnology Innovation Organization, Fusion Pharmaceuticals, Iota BioSciences, Landos Biopharma, LEO Science Hub, NewLink Genetics, Newron Pharmaceuticals, Oncocyte, Origenis, Savara, Xontogeny LLC and other emerging health and science companies. Follow LHS on Twitter at @LaVoieGroup.

Media Contact:
Beth Kurth
Vice President, Investor Relations
bkurth@lavoiehealthscience.com
617-374-8800 x106

 

LaVoieHealthScience Continues to Add to Public Company Client Roster

LaVoieHealthScience Continues to Add to Public Company Client Roster

Integrity Applications and Savara Pharmaceuticals Join LHS Portfolio of PR/IR Clients

Boston, MA – November 9, 2017 — LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced two additional public company clients, Integrity Applications and Savara Pharmaceuticals. These clients join a prestigious group of innovative health and science companies that are represented by LHS for their investor and/or public relations solutions.

Integrity Applications (OTCMKTS: IGAP), founded in 2001 and is focused on the design, development, and commercialization of non-invasive glucose monitoring technologies for people with type 2 diabetes and prediabetes. The company has developed GlucoTrack®, a proprietary non-invasive glucose monitoring device designed to obtain glucose level measurements in about a minute without the pain, incremental cost, difficulty, or discomfort of conventional invasive finger stick devices.

Savara Pharmaceuticals (NASDAQ: SVRA), went public through a reverse merger with Mast Therapeutics in 2017. Based in West Lake Hills, TX, Savara is an emerging pharmaceutical development company focused on advancing a pipeline of novel inhalation therapies for the treatment of patients with rare pulmonary conditions. Savara has three investigational products in various stages of clinical development: Molgradex, the first inhaled product being developed for the treatment of patients with Pulmonary Alveolar Proteinosis and Nontuberculous Mycobacterial (NTM) Lung Infection; AeroVanc, an inhaled dry powder form of vancomycin to treat Methicillin-resistant Staphylococcus aureus (MRSA) lung infection in cystic fibrosis patients; and Aironite, which is inhaled via nebulizer to treat heart failure patients with preserved ejection fraction. Savara has an affiliate company based in Hørsholm, Denmark.

“Our integrated public and investor relations offerings, building on our team’s expertise is validated by these new client wins,” said Donna L. LaVoie, President & CEO of LaVoieHealthScience. “Each client has very specific business objectives in which our industry-tested strategic communications programs are being implemented. Aligning with true innovators in the health and science field is our passion.”

About LaVoieHealthScience
LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 29 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients, and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. In addition to clients listed above, LaVoieHealthScience represents leaders such as Biotechnology Innovation Organization, Fusion Pharmaceuticals, Iota BioSciences, Landos Biopharma, LEO Science Hub, NewLink Genetics, Newron Pharmaceuticals, Origenis, Xontogeny LLC and other emerging health and science companies.

###

Media Contact:
Ryan Donovan
rdonovan@lavoiehealthscience.com
617-374-8800 x102

Coordinating Messages When Companies Join Forces

Click the image to read more.

By Donna LaVoie

Life science companies, including big and small pharma, biotech and health technology, continue the trend toward partnerships to research, develop and/or commercialize their innovations, allowing companies to enter new markets, continue niche disease research and development and introduce innovations sooner. Adding to the mix are accelerators and venture firms launching new companies into the health science and technology ecosystem.

Even though they are joining forces, and likely have the same end-goal, each of these companies will have a unique, and sometimes competing, set of communications and business goals. They also may have different priorities on stakeholder mix. While it’s easy to default to the needs of the larger company, strategic communications entails finding ways to balance the needs of all parties in the transaction.

Read more at O’Dwyer’s.

LaVoieHealthScience Adds Former Analyst & Welcomes New PR & IR Clients

LaVoieHealthScience Adds Former Analyst, Chiara Russo to Its Investor Relations Team

Welcomes New PR & IR Clients to its Roster

…LHS Makes Inc. 5000 List for 4th Time

 

Boston, MA – August 24, 2017 —  LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced that former specialty pharmaceutical analyst, Chiara Russo joined the LHS team as Director, Investor Relations. In addition, LHS announced new clients, the life science accelerator, Xontogeny LLC and electroceutical pioneer, Iota BioSciences.

Ms. Russo joins LHS from Cantor Fitzgerald, LLC, where she was Director, Research Analyst covering various small to mid-cap specialty pharma/biotech companies across a multitude of therapeutic areas leading to a significant industry network.  She has been quoted in many news outlets such as Bloomberg, Reuter, TheStreet and Bezinga and accompanied company executives on numerous non-deal roadshows in major investor centers.  Prior to her role at Cantor, Chiara was Vice President, Research Analyst at Janney Montgomery Scott, LLC, having started her career at Think Equity LLC.

“Continuing to add experienced health and science communications talent to our team is an important part of our strategy for growth,” said Donna L. LaVoie, President & CEO of LaVoieHealthScience. “With our continued focus in providing an integrated solution in both investor and public relations to our clients, adding Chiara to the team provides us with additional bench strength in IR and financial communications.”

“I am excited to already be applying my skills as an analyst to help LHS’ clients with story-telling and their investment thesis along with an insider’ view on how news is viewed and potential institutional targets,” said Russo.

Xontogeny LLC, founded by former Sarepta CEO and serial entrepreneur, Chris Garabedian, is a biotech aggregator that supports the accelerated development of life science technologies in the pursuit of helping patients with serious diseases.  Xontogeny partners with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.

Iota BioSciences, founded in Berkeley, CA, is an emerging electroceutical company revolutionizing the use of “vanishingly small” wireless, battery less sensors, bringing closer a time when a Fitbit-like device could monitor internal nerves, muscles, or organs in real time.

“As this is our fourth time making the Inc. 5000 fastest-growing private company list, we are proud of the team’s accomplishments and to add these clients to our list of movers and shakers in the health and sciences field,” said Donna LaVoie, President & CEO of LaVoieHealthScience. “The LHS team is excited to help these emerging health and science innovators add value and grow.”

About LaVoieHealthScience

LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 29 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients, and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. In addition to clients listed above, LaVoieHealthScience represents leaders such as Biotechnology Innovation Organization, Cydan Development, Imara, NewLink Genetics, Newron Pharmaceuticals, Origenis, and other emerging health and science companies.

###

Contact:
Beth Kurth
Vice President, Investor Relations
bkurth@lavoiehealthscience.com
617-374-8800 x106

LaVoieHealthScience Clients Recognized by Xconomy

 LaVoieHealthScience Clients Recognized by Xconomy

LEO Science & Tech Hub and Xontogeny Selected as Award Finalists

LaVoieHealthScience, an integrated investor and public relations agency focused on advancing health and science innovations, today announced that two clients, LEO Science & Tech Hub and Xontogeny are finalists for the 2017 Xconomy awards!  The Xconomy awards honor the top people, companies and organizations that make the Boston life sciences community one of the most vibrant innovation centers in the world during Biotech Week Boston.

Chris Garabedian, CEO of Xontogeny is a finalist in the Contrarian category and LEO Science & Tech Hub in the Newcomer category.

The Xconomy Awards are part of the Biotech Week in Boston and will be presented at the awards gala on September 26th.

About LaVoieHealthScience

LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 28 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients. In addition to clients listed above, LaVoieHealthScience represents leaders such as Cydan Development, Imara, NewLink Genetics, Biotechnology Innovation Organization, Newron Pharmaceuticals, Origenis, and other emerging health and science companies.

Donna LaVoie to Present “The LHS Fifteen-Slide Presentation®” at Venture Cafe

You’re Invited: “The LHS Fifteen-Slide Presentation®

Venture Café at The Cambridge Innovation Center (CIC)

Thursday, August 24, 5:30 – 6:30 p.m.

 

You are invited to join Donna LaVoie, President & CEO of LaVoieHealthScience, for her trademarked workshop “The LHS Fifteen-Slide Presentation®” on August 24 from 5:30-6:30 pm ET at the Venture Cafe, One Broadway, Kendall Square, Cambridge. First presented at BIO International in 2016, the workshop was offered again in 2017 to a standing-room-only crowd and is now available on the East Coast!

This workshop covers how to create an engaging company presentation in just 15 slides.   At this interactive session, attendees will learn:

  • The basics of a great presentation including slides to cover the science and business strategy
  • The qualities of a great presentation including how to be both succinct and specific

To prepare for the workshop, attendees can download and fill out the “Creating Your Elevator Pitch” worksheet by following the link below. This document is the first essential part of crafting effective presentation slides.

Please RSVP to Ryan Donovan, rdonovan@lavoiehealthscience.com

We look forward to seeing you.